Sugammadex (Bridion; Merck) is a small-molecule oligosaccharide, also known as a modified gamma cyclodextin, that was ...
COUR Pharmaceuticals has been around a while, but not until last year did the company solidify behind its ultimate mission ...
It’s show-me time for batoclimab, an antibody treatment from Immunovant and Roivant Sciences. Here's what you need to know.
1d
MedPage Today on MSNTwo Investigational Treatments for ALS Show Glimmer of HopeThe first four treatments in a platform trial for amyotrophic lateral sclerosis (ALS) failed to reach key endpoints in phase ...
The Vivacity-MG3 study is currently in its open-label extension phase, which is investigating the longer-term safety and ...
THE occurrence of thyrotoxicosis in patients with myasthenia gravis is not rare, over 90 such cases having been reported since the turn of the century. 1,2 Various estimates place the incidence of ...
Country star Colt Ford shared that he and Jelly Roll were able to bond over what it’s like to be the “big guys.” ...
Reports Q4 revenue $298.0M, consensus $285.7M. “I am excited to announce that the significant growth we achieved throughout the year culminated ...
Biopharma doubles down on immunology and inflammation as companies target new pathways and seek to improve on current options in inflammatory bowel disease, atopic dermatitis, myasthenia gravis and ...
To learn this, the researchers measured the effect of Vyvgart using a test called the Myasthenia Gravis-Specific Activities of Daily Living scale (MG-ADL), which shows how gMG affects daily ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results